Tharimmune, Inc.
NASDAQ Capital MarketTotal Valuation
Tharimmune, Inc. carries a market capitalization of 139.94M, placing it among publicly traded companies globally. Its enterprise value stands at -5.22M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 139.94M |
| Enterprise Value | -5.22M |
Share Statistics
Tharimmune, Inc. currently has 37.39M shares outstanding.
| Shares Outstanding | 37.39M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.16 |
| P/TBV Ratio | -0.11 |
| P/FCF Ratio | -0.73 |
| P/OCF Ratio | -0.73 |
Financial Position
Tharimmune, Inc. maintains a current ratio of 5.29, meaning it holds 5.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 5.29 |
| Quick Ratio | 5.18 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -709.33 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -13.74 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Tharimmune, Inc.'s stock has gained approximately 158.39416% over the past 52 weeks. The 50-day moving average sits at 3.47, while the 200-day moving average is 2.73.
| Beta (5Y) | N/A |
| 52-Week Price Change | 158.39416% |
| 50-Day Moving Average | 3.47 |
| 200-Day Moving Average | 2.73 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -20.11M, while operating income came in at -20.11M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -20.11M |
| Pretax Income | -42.10M |
| Net Income | -35.92M |
| EBITDA | -20.11M |
| EBIT | -20.11M |
| Earnings Per Share (EPS) | -9.22 |
Balance Sheet
Total book value stands at -72.81M, with working capital of 14.10M providing operational flexibility.
| Cash & Cash Equivalents | 17.03M |
| Total Debt | N/A |
| Net Debt | -17.03M |
| Equity (Book Value) | -72.81M |
| Book Value Per Share | -18.68 |
| Working Capital | 14.10M |
Cash Flow
Tharimmune, Inc. produced -16.13M in operating cash flow over the past twelve months.
| Operating Cash Flow | -16.13M |
| Capital Expenditures | N/A |
| Free Cash Flow | -16.13M |
| FCF Per Share | -4.14 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -907.57 |
| FCF Yield | -136.58 |
Stock Splits
Tharimmune, Inc.'s most recent stock split took place on May 28, 2024 with a 15:1 split ratio.
| Last Split Date | 5/28/2024 |
| Split Ratio | 15:1 |
Scores
Tharimmune, Inc. posts an Altman Z-Score of -8.65, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -8.65 |